In addition, MAPK9, MOGAT2, and PIK3R3 in the LMRS model exhibited significant survival differences in survival analysis among all TCGA-HNSCC patients with a p value < 0.05 (Fig. 4A–H). This evidence concerns the gene MOGAT2 and head and neck squamous cell carcinoma.